Improvement of outcome after fatty liver transplantation
脂肪肝移植术后预后的改善
基本信息
- 批准号:13671229
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transplantation of livers with severe steatosis may result, in primary nonfunction of the grafts. Protective strategies are very rare to safely expand the donor pool to fatty liver. Hepatocyte Growth Factor (HGF) is known as the most potent mitogen for hepatocytes and has been shown to have protective effect and stimulate regeneration in injured livers. Here we examined the effects of human recombinant HGF (hrHGF) on function and survival of preserved fatty liver transplantation. Fatty livers obtained from choline-methionine-deficient diet -fed rats were orthotopically transplanted in normal rats after 12-hour cold preservation. In the HGF group, donor rats were pretreated with hrHGF, and hrHGF was also added to the preservation solution. Twelve hours after hrHGF injection, lipid analyses demonstrated increased serum levels of triglyceride, total cholesterol, low density lipoprotein and very low density lipoprotein. Recipient rat survival was significantly increased in hrHGF-pretreated group compared with control. Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) levels in the effluent before graft revascularization and serum ALT, LDH and HA at 2 hour after reperfusion were significantly low in FLGF group, accompanied with increased hyaluronic acid uptake rate. Pretreatment with hrHGF also significantly reduced the TUNEL positive cells and increased BrdU positive hepatocytes at 2 hour after reperfusion. Sinusoidal endothelial cells (SECs) damage and hepatocyte apoptosis were more severe in control group observed by transmission electron microscope. In conclusion, hrHGF has both protective effects on hepatocytes and SECs at fatty liver transplantation. It inhibited apoptosis of fatty liver during preservation reperfusion injury and induced graft regeneration at early stage after transplantation. Also it might lead to recovery of steatosis by increasing secretion of lipids out of liver.
严重脂肪变性的肝脏移植可能导致移植物原发性无功能。保护性策略非常罕见,可以安全地将供体库扩大到脂肪肝。肝细胞生长因子(HGF)是肝细胞最有效的有丝分裂原,已被证明具有保护作用,并刺激损伤肝脏的再生。在这里,我们研究了人重组肝细胞生长因子(hrHGF)对保存脂肪肝移植的功能和生存的影响。从胆碱-蛋氨酸缺乏饮食喂养的大鼠获得的脂肪肝在冷保存12小时后原位移植到正常大鼠体内。肝细胞生长因子组(HGF组),供体大鼠经hrHGF预处理后,在保存液中加入hrHGF。hrHGF注射后12小时,脂质分析显示甘油三酯、总胆固醇、低密度脂蛋白和极低密度脂蛋白的血清水平升高。与对照组相比,hrHGF预处理组受体大鼠的生存率显着增加。FLGF组血运重建前流出液中AST、ALT和LDH水平及再灌注后2 h血清ALT、LDH和HA水平均显著降低,透明质酸摄取率升高。再灌注后2小时,hrHGF预处理也显著减少TUNEL阳性细胞,增加BrdU阳性肝细胞。透射电子显微镜观察对照组肝窦内皮细胞(SEC)损伤和肝细胞凋亡较严重。总之,hrHGF对脂肪肝移植中的肝细胞和SEC具有保护作用。抑制脂肪肝保存再灌注损伤中的细胞凋亡,并在移植后早期诱导移植肝再生。它也可能通过增加肝脏的脂质分泌而导致脂肪变性的恢复。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Michihiro Hayashi: "Current strategies for the use of sub-optimal grafts in living-donor liver transplantation"TRANSPLANTATION PROCEEDINGS. 34(7). 2567-2568 (2001)
Michihiro Hayashi:“活体肝移植中使用次优移植物的当前策略”移植程序。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAYASHI Michihiro其他文献
Specific binding of HLA-A32, -B13 and -B62 molecules to human monocyte/macrophage MHC receptor 2 on monocytes
HLA-A32、-B13 和 -B62 分子与单核细胞上的人单核细胞/巨噬细胞 MHC 受体 2 特异性结合
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
YAMANA Hidenori;TASHIRO-YAMAJI Junko;SHIMIZU Tetsunosuke;HAYASHI Michihiro;TANIGAWA Nobuhiko;UCHIYAMA Kazuhisa;KUBOTA Takahiro;YOSHIDA Ryotaro. - 通讯作者:
YOSHIDA Ryotaro.
HAYASHI Michihiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAYASHI Michihiro', 18)}}的其他基金
The role of chymase in the disease preocess of non-alcoholic staetohepatitis (NASH)
食糜酶在非酒精性脂肪性肝炎(NASH)发病过程中的作用
- 批准号:
23591999 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
- 批准号:
MR/X008827/1 - 财政年份:2024
- 资助金额:
$ 2.24万 - 项目类别:
Research Grant
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients (Artemis)
加速虚拟双胞胎向脂肪肝患者个性化管理的转化(Artemis)
- 批准号:
10109933 - 财政年份:2024
- 资助金额:
$ 2.24万 - 项目类别:
EU-Funded
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
- 批准号:
10646759 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
脂肪肝疾病和血脂异常中的 NADH-ChREBP 轴
- 批准号:
10564369 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Development of Early Diagnostic Markers for Non-Alcoholic Fatty Liver Disease (NAFLD) and Investigation of Inflammatory Mechanisms of NAFLD
非酒精性脂肪性肝病(NAFLD)早期诊断标志物的开发及NAFLD炎症机制的研究
- 批准号:
23K07466 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tackling the fatty liver by targeting the gut
通过针对肠道来解决脂肪肝
- 批准号:
2869577 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease
非酒精性脂肪肝中基因组与重金属的相互作用
- 批准号:
10658148 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease
AAV 介导的 PIK3C2B 基因敲低作为 X 连锁肌管肌病和脂肪肝的治疗策略
- 批准号:
10753786 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Bacteriotherapy to treat non-alcoholic fatty liver disease
细菌疗法治疗非酒精性脂肪肝
- 批准号:
2893992 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Investigating folliculin as a regulator of VLDL-TG secretion in non-alcoholic fatty liver disease and steatohepatitis
研究卵泡素作为非酒精性脂肪肝和脂肪性肝炎中 VLDL-TG 分泌的调节剂
- 批准号:
10679361 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别: